Obeticholic acid improves experimental non-invasive markers of non-alcoholic steatohepatitis and advanced fibrosis: a secondary analysis of the phase 3 regenerate study

2020 ◽  
Vol 73 ◽  
pp. S54
Author(s):  
Jerome Boursier ◽  
Rohit Loomba ◽  
Quentin Anstee ◽  
Stephen Harrison ◽  
Arun Sanyal ◽  
...  
Keyword(s):  
Secondary Analysis ◽  
Advanced Fibrosis ◽  
Obeticholic Acid ◽  
Phase 3 ◽  
Non Invasive ◽  
Alcoholic Steatohepatitis

SAT-273-Impact of age on routinely available non-invasive tests for the discrimination of advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib

2019 ◽  
Vol 70 (1) ◽  
pp. e754-e755
Author(s):  
Naim Alkhouri ◽  
Zobair M. Younossi ◽  
Eric Lawitz ◽  
Vincent Wai-Sun Wong ◽  
Manuel Romero Gomez ◽  
...  
Keyword(s):  
Advanced Fibrosis ◽  
Phase 3 ◽  
Non Invasive

scholarly journals Serious complications due to study-mandated liver biopsies in phase 3 trials for patients with advanced fibrosis due to non-alcoholic steatohepatitis

2020 ◽  
Vol 73 ◽  
pp. S164
Author(s):  
Quentin Anstee ◽  
Keyur Patel ◽  
Castera Laurent ◽  
Mitchell Shiffman ◽  
Mang M ◽  
...  
Keyword(s):  
Advanced Fibrosis ◽  
Phase 3 ◽  
Alcoholic Steatohepatitis ◽  
Liver Biopsies

scholarly journals Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials

2020 ◽  
Vol 73 ◽  
pp. S157-S158
Author(s):  
Mazen Noureddin ◽  
Jörn M. Schattenberg ◽  
Javier Crespo ◽  
Masayuki Kurosaki ◽  
Chi-Yi Chen ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Events ◽  
Advanced Fibrosis ◽  
Phase 3 ◽  
Alcoholic Steatohepatitis
Sign in / Sign up

Export Citation Format

Share Document